Dr. Leo Nissola, an immunotherapy scientist and adviser to COVID Act Now, joined CBSN to discuss the latest on U.S. vaccination efforts and a clinical trial studying the safety of a potential COVID-19 drug called Ivermectin. Source
Dr. Leo Nissola, an immunotherapy scientist and adviser to COVID Act Now, joined CBSN to discuss the latest on U.S. vaccination efforts and a clinical trial studying the safety of a potential COVID-19 drug called Ivermectin. Source